Corrigendum: Targeting innate immunity in breast cancer therapy: a narrative review

Front Immunol. 2023 Dec 20:14:1353708. doi: 10.3389/fimmu.2023.1353708. eCollection 2023.

¹ Zenomics. Inc. Magnify at California NanoSystems Institute, Los Angeles, CA, United States.
² School of Dentistry, The University of Queensland, Brisbane, QLD, Australia.
³ School of Medicine, University of Maryland, Baltimore, MD, United States.
⁴ School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
⁵ Department of Otolaryngology - Head and Neck Surgery, University of California at San Francisco, San Francisco, CA, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.771201.].

Keywords: breast cancer; cancer immunotherapy; clinical studies; innate immunity; vaccine adjuvants.